Mankind Pharma Limited (BOM:543904)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 960.38 billion. The enterprise value is 920.18 billion.

Market Cap	960.38B
Enterprise Value	920.18B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	105.88M

Valuation Ratios

The trailing PE ratio is 47.04.

PE Ratio	47.04
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	10.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	45.08
EV / Sales	7.90
EV / EBITDA	31.62
EV / EBIT	37.26
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	0.17
Debt / FCF	n/a
Interest Coverage	10.10

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.29%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	5.96M
Profits Per Employee	1.04M
Employee Count	19,540
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.17%
50-Day Moving Average	2,632.95
200-Day Moving Average	2,431.87
Relative Strength Index (RSI)	37.27
Average Volume (20 Days)	11,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 116.41 billion and earned 20.41 billion in profits. Earnings per share was 50.81.

Revenue	116.41B
Gross Profit	81.70B
Operating Income	24.57B
Pretax Income	25.86B
Net Income	20.41B
EBITDA	28.93B
EBIT	24.57B
Earnings Per Share (EPS)	50.81

Balance Sheet

The company has 47.27 billion in cash and 4.82 billion in debt, giving a net cash position of 42.45 billion.

Cash & Cash Equivalents	47.27B
Total Debt	4.82B
Net Cash	42.45B
Net Cash Per Share	n/a
Equity (Book Value)	107.89B
Book Value Per Share	263.72
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 70.18%, with operating and profit margins of 21.11% and 17.54%.

Gross Margin	70.18%
Operating Margin	21.11%
Pretax Margin	22.21%
Profit Margin	17.54%
EBITDA Margin	24.85%
EBIT Margin	21.11%
FCF Margin	n/a

Dividends & Yields

Mankind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	-0.20%
Earnings Yield	2.13%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a